Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5-exo-hydroxycamphor dehydrogenase is a bacterial enzyme, primarily characterized in Pseudomonas putida, that plays a vital role in the degradation of camphor [1]. It is encoded by the camD gene and belongs to the short-chain dehydrogenase/reductase (SDR) superfamily [1, 3]. The enzyme specifically catalyzes the NAD+-dependent oxidation of 5-exo-hydroxycamphor to form 2,5-diketocamphane, which is a necessary step for the bacterium to utilize camphor as a sole carbon and energy source [2, 3]. While it is a well-studied model for understanding enzyme specificity and microbial metabolic operons, it is not currently recognized as a therapeutic target for human diseases [1, 2]. The enzyme exhibits high stereospecificity, favoring the exo-isomer of its substrate over the endo-isomer [2]. Its primary significance lies in the fields of environmental microbiology, bioremediation, and potential applications in industrial biocatalysis [2, 3]. Structural analysis has confirmed its reliance on the NAD+ cofactor for its catalytic mechanism [1].
Catalyzes the NAD+-dependent oxidation of 5-exo-hydroxycamphor to 2,5-diketocamphane as part of the camphor catabolic pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-exo-hydroxycamphor dehydrogenase (camD).